Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
Add more filters










Publication year range
1.
J Mol Biol ; 433(22): 167244, 2021 11 05.
Article in English | MEDLINE | ID: mdl-34537235

ABSTRACT

The basic molecular mechanism underlying mammalian oxygen-dependent regulation of hypoxia-inducible factor (HIF) via the von Hippel-Lindau E3 ubiquitin ligase is well established. The principal step in this critical cellular process is the hydroxylation of either or both of the two conserved proline residues P402 and P564 within the oxygen-dependent degradation domain (ODD) of HIF-1α subunit via prolyl hydroxylases, which is necessary for binding VHL. However, the significance of the two prolines has remained unclear considering that only one hydroxyproline is sufficient for the recruitment of VHL. Here, we show using biophysical analyses that both hydroxyprolines bind to the same interface on VHL with similar affinity; VHL binding affinity to HIF-1α ODD remains relatively unchanged regardless of whether the ODD contains one or two hydroxyprolines; ODD with two hydroxyprolines can accommodate two VHLs; and the rate of in vitro ubiquitination of ODD with one hydroxyproline via VHL E3 ligase is comparable to the rate observed with ODD containing two hydroxyprolines. However, the two hydroxyprolines show distinct contributions to the intracellular stability of HIF-1α ODD. These results demonstrate for the first time that the graduated HIF-1α stability profile observed over a range of oxygen tension is not attributed to the binding of or ubiquitination via VHL per se, but is likely due to the preceding events such as the efficacy of oxygen-dependent prolyl hydroxylase-mediated hydroxylation of HIF-1α.


Subject(s)
Hydroxyproline/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Von Hippel-Lindau Tumor Suppressor Protein/metabolism , Binding, Competitive , Circular Dichroism , HEK293 Cells , Humans , Hydroxylation , Hydroxyproline/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Mutation , Oxygen/metabolism , Protein Domains , Protein Stability , Ubiquitination , Von Hippel-Lindau Tumor Suppressor Protein/genetics
2.
Biomolecules ; 11(9)2021 09 15.
Article in English | MEDLINE | ID: mdl-34572577

ABSTRACT

The calcitonin and amylin receptors (CTR and AMY receptors) are the drug targets for osteoporosis and diabetes treatment, respectively. Salmon calcitonin (sCT) and pramlintide were developed as peptide drugs that activate these receptors. However, next-generation drugs with improved receptor binding profiles are desirable for more effective pharmacotherapy. The extracellular domain (ECD) of CTR was reported as the critical binding site for the C-terminal half of sCT. For the screening of high-affinity sCT analog fragments, purified CTR ECD was used for fluorescence polarization/anisotropy peptide binding assay. When three mutations (N26D, S29P, and P32HYP) were introduced to the sCT(22-32) fragment, sCT(22-32) affinity for the CTR ECD was increased by 21-fold. CTR was reported to form a complex with receptor activity-modifying protein (RAMP), and the CTR:RAMP complexes function as amylin receptors with increased binding for the peptide hormone amylin. All three types of functional AMY receptor ECDs were prepared and tested for the binding of the mutated sCT(22-32). Interestingly, the mutated sCT(22-32) also retained its high affinity for all three types of the AMY receptor ECDs. In summary, the mutated sCT(22-32) showing high affinity for CTR and AMY receptor ECDs could be considered for developing the next-generation peptide agonists.


Subject(s)
Calcitonin/analogs & derivatives , Extracellular Space/chemistry , Receptors, Calcitonin/chemistry , Amino Acid Sequence , Animals , Calcitonin/chemistry , Calcitonin/genetics , HEK293 Cells , Humans , Hydroxyproline/genetics , Mutation/genetics , Protein Domains , Salmon
3.
PLoS One ; 15(10): e0241250, 2020.
Article in English | MEDLINE | ID: mdl-33119652

ABSTRACT

With the advent of highly sensitive technologies such as tandem mass spectrometry and next-generation sequencing, recombinant antibodies are now routinely analyzed for the presence of low-level sequence variants including amino acid misincorporations. During mAb cell culture process development, we found that proline was replaced with the non-canonical amino acid, hydroxyproline, in the protein sequence. We investigated the relationship between proline content in the cell culture media and proline sequence variants and found that the proline concentration was inversely correlated with the amount of sequence variants detected in the protein sequence. Hydroxyproline incorporation has been previously reported in recombinant proteins produced in mammalian expression systems as a post-translational modification. Given the dependency on proline levels, the mechanism was then investigated. To address the possibility of co-translational misincorporation of hydroxyproline, we used tandem mass spectrometry to measure incorporation of stable-isotope labelled hydroxyproline added to the feed of a production bioreactor. We discovered co-translational misincorporation of labelled hydroxyproline in the recombinant antibody. These findings are significant, since they underscore the need to track non-canonical amino acid incorporation as a co-translational event in CHO cells. Understanding the mechanism of hydroxyproline incorporation is crucial in developing an appropriate control strategy during biologics production.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Bioreactors , Hydroxyproline/metabolism , Protein Processing, Post-Translational , Animals , Antibodies, Monoclonal/genetics , CHO Cells , Cricetulus , Hydroxyproline/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics
4.
Biotechnol Bioeng ; 117(4): 945-958, 2020 04.
Article in English | MEDLINE | ID: mdl-31930479

ABSTRACT

Reconstructing the chemical and structural characteristics of the plant cell wall represents a promising solution to overcoming lignocellulosic biomass recalcitrance to biochemical deconstruction. This study aims to leverage hydroxyproline (Hyp)-O-glycosylation, a process unique to plant cell wall glycoproteins, as an innovative technology for de novo design and engineering in planta of Hyp-O-glycosylated biopolymers (HypGP) that facilitate plant cell wall reconstruction. HypGP consisting of 18 tandem repeats of "Ser-Hyp-Hyp-Hyp-Hyp" motif or (SP4)18 was designed and engineered into tobacco plants as a fusion peptide with either a reporter protein enhanced green fluorescence protein or the catalytic domain of a thermophilic E1 endoglucanase (E1cd) from Acidothermus cellulolyticus. The engineered (SP4)18 module was extensively Hyp-O-glycosylated with arabino-oligosaccharides, which facilitated the deposition of the fused protein/enzyme in the cell wall matrix and improved the accumulation of the protein/enzyme in planta by 1.5-11-fold. The enzyme activity of the recombinant E1cd was not affected by the fused (SP4)18 module, showing an optimal temperature of 80°C and optimal pH between 5 and 8. The plant biomass engineered with the (SP4)18 -tagged protein/enzyme increased the biomass saccharification efficiency by up to 3.5-fold without having adverse impact on the plant growth.


Subject(s)
Biopolymers , Cell Wall , Genetic Engineering/methods , Plants, Genetically Modified , Recombinant Fusion Proteins , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biomass , Biopolymers/chemistry , Biopolymers/genetics , Biopolymers/metabolism , Cell Wall/chemistry , Cell Wall/metabolism , Cellulase/chemistry , Cellulase/genetics , Cellulase/metabolism , Glycoproteins , Glycosylation , Hydroxyproline/chemistry , Hydroxyproline/genetics , Hydroxyproline/metabolism , Plant Proteins , Plants, Genetically Modified/cytology , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Nicotiana/cytology , Nicotiana/genetics , Nicotiana/metabolism
5.
Int J Mol Sci ; 20(10)2019 May 25.
Article in English | MEDLINE | ID: mdl-31130622

ABSTRACT

Plants frequently encounter diverse abiotic stresses, one of which is environmental thermal stress. To cope with these stresses, plants have developed a range of mechanisms, including altering the cell wall architecture, which is facilitated by the arabinogalactan proteins (AGP) and extensins (EXT). In order to characterise the localisation of the epitopes of the AGP and EXT, which are induced by the stress connected with a low (4 °C) or a high (40 °C) temperature, in the leaves of Brachypodium distachyon, we performed immunohistochemical analyses using the antibodies that bind to selected AGP (JIM8, JIM13, JIM16, LM2 and MAC207), pectin/AGP (LM6) as well as EXT (JIM11, JIM12 and JIM20). The analyses of the epitopes of the AGP indicated their presence in the phloem and in the inner bundle sheath (JIM8, JIM13, JIM16 and LM2). The JIM16 epitope was less abundant in the leaves from the low or high temperature compared to the control leaves. The LM2 epitope was more abundant in the leaves that had been subjected to the high temperatures. In the case of JIM13 and MAC207, no changes were observed at the different temperatures. The epitopes of the EXT were primarily observed in the mesophyll and xylem cells of the major vascular bundle (JIM11, JIM12 and JIM20) and no correlation was observed between the presence of the epitopes and the temperature stress. We also analysed changes in the level of transcript accumulation of some of the genes encoding EXT, EXT-like receptor kinases and AGP in the response to the temperature stress. In both cases, although we observed the upregulation of the genes encoding AGP in stressed plants, the changes were more pronounced at the high temperature. Similar changes were observed in the expression profiles of the EXT and EXT-like receptor kinase genes. Our findings may be relevant for genetic engineering of plants with increased resistance to the temperature stress.


Subject(s)
Brachypodium/metabolism , Glycoproteins/metabolism , Hydroxyproline/metabolism , Plant Leaves/metabolism , Plant Proteins/metabolism , Brachypodium/genetics , Cold-Shock Response , Gene Expression Regulation, Plant , Glycoproteins/genetics , Heat-Shock Response , Hydroxyproline/genetics , Mucoproteins/genetics , Mucoproteins/metabolism , Plant Leaves/genetics , Plant Proteins/genetics
6.
J Bacteriol ; 199(16)2017 08 15.
Article in English | MEDLINE | ID: mdl-28559297

ABSTRACT

Hydroxyprolines, such as trans-4-hydroxy-l-proline (T4LHyp), trans-3-hydroxy-l-proline (T3LHyp), and cis-3-hydroxy-l-proline (C3LHyp), are present in some proteins including collagen, plant cell wall, and several peptide antibiotics. In bacteria, genes involved in the degradation of hydroxyproline are often clustered on the genome (l-Hyp gene cluster). We recently reported that an aconitase X (AcnX)-like hypI gene from an l-Hyp gene cluster functions as a monomeric C3LHyp dehydratase (AcnXType I). However, the physiological role of C3LHyp dehydratase remained unclear. We here demonstrate that Azospirillum brasilense NBRC 102289, an aerobic nitrogen-fixing bacterium, robustly grows using not only T4LHyp and T3LHyp but also C3LHyp as the sole carbon source. The small and large subunits of the hypI gene (hypIS and hypIL, respectively) from A. brasilense NBRC 102289 are located separately from the l-Hyp gene cluster and encode a C3LHyp dehydratase with a novel heterodimeric structure (AcnXType IIa). A strain disrupted in the hypIS gene did not grow on C3LHyp, suggesting its involvement in C3LHyp metabolism. Furthermore, C3LHyp induced transcription of not only the hypI genes but also the hypK gene encoding Δ1-pyrroline-2-carboxylate reductase, which is involved in T3LHyp, d-proline, and d-lysine metabolism. On the other hand, the l-Hyp gene cluster of some other bacteria contained not only the AcnXType IIa gene but also two putative proline racemase-like genes (hypA1 and hypA2). Despite having the same active sites (a pair of Cys/Cys) as hydroxyproline 2-epimerase, which is involved in the metabolism of T4LHyp, the dominant reaction by HypA2 was clearly the dehydration of T3LHyp, a novel type of T3LHyp dehydratase that differed from the known enzyme (Cys/Thr).IMPORTANCE More than 50 years after the discovery of trans-4-hydroxy-l-proline (generally called l-hydroxyproline) degradation in aerobic bacteria, its genetic and molecular information has only recently been elucidated. l-Hydroxyproline metabolic genes are often clustered on bacterial genomes. These loci frequently contain a hypothetical gene(s), whose novel enzyme functions are related to the metabolism of trans-3-hydroxyl-proline and/or cis-3-hydroxyl-proline, a relatively rare l-hydroxyproline in nature. Several l-hydroxyproline metabolic enzymes show no sequential similarities, suggesting their emergence by convergent evolution. Furthermore, transcriptional regulation by trans-4-hydroxy-l-proline, trans-3-hydroxy-l-proline, and/or cis-3-hydroxy-l-proline significantly differs between bacteria. The results of the present study show that several l-hydroxyprolines are available for bacteria as carbon and energy sources and may contribute to the discovery of potential metabolic pathways of another hydroxyproline(s).


Subject(s)
Azospirillum brasilense/enzymology , Hydro-Lyases/isolation & purification , Hydro-Lyases/metabolism , Hydroxyproline/metabolism , Azospirillum brasilense/genetics , Azospirillum brasilense/growth & development , Azospirillum brasilense/metabolism , Carbon/metabolism , Gene Knockout Techniques , Hydroxyproline/genetics , Multigene Family , Protein Subunits/genetics , Protein Subunits/metabolism , Transcription, Genetic
7.
Biotechnol Bioeng ; 114(7): 1511-1520, 2017 07.
Article in English | MEDLINE | ID: mdl-28266022

ABSTRACT

Amino acid hydroxylases depend directly on the cellular TCA cycle via their cosubstrate α-ketoglutarate (α-KG) and are highly useful for the selective biocatalytic oxyfunctionalization of amino acids. This study evaluates TCA cycle engineering strategies to force and increase α-KG flux through proline-4-hydroxylase (P4H). The genes sucA (α-KG dehydrogenase E1 subunit) and sucC (succinyl-CoA synthetase ß subunit) were alternately deleted together with aceA (isocitrate lyase) in proline degradation-deficient Escherichia coli strains (ΔputA) expressing the p4h gene. Whereas, the ΔsucCΔaceAΔputA strain grew in minimal medium in the absence of P4H, relying on the activity of fumarate reductase, growth of the ΔsucAΔaceAΔputA strictly depended on P4H activity, thus coupling growth to proline hydroxylation. P4H restored growth, even when proline was not externally added. However, the reduced succinyl-CoA pool caused a 27% decrease of the average cell size compared to the wildtype strain. Medium supplementation partially restored the morphology and, in some cases, enhanced proline hydroxylation activity. The specific proline hydroxylation rate doubled when putP, encoding the Na+ /l-proline transporter, was overexpressed in the ΔsucAΔaceAΔputA strain. This is in contrast to wildtype and ΔputA single-knock out strains, in which α-KG availability obviously limited proline hydroxylation. Such α-KG limitation was relieved in the ΔsucAΔaceAΔputA strain. Furthermore, the ΔsucAΔaceAΔputA strain was used to demonstrate an agar plate-based method for the identification and selection of active α-KG dependent hydroxylases. This together with the possibility to waive selection pressure and overcome α-KG limitation in respective hydroxylation processes based on living cells emphasizes the potential of TCA cycle engineering for the productive application of α-KG dependent hydroxylases. Biotechnol. Bioeng. 2017;114: 1511-1520. © 2017 Wiley Periodicals, Inc.


Subject(s)
Citric Acid Cycle/genetics , Escherichia coli/physiology , Genetic Enhancement/methods , Hydroxyproline/biosynthesis , Ketoglutaric Acids/metabolism , Mixed Function Oxygenases/metabolism , Catalysis , Gene Expression Regulation, Bacterial/physiology , Gene Expression Regulation, Enzymologic/physiology , Hydroxyproline/genetics , Mixed Function Oxygenases/genetics , Protein Engineering/methods
8.
J Biomed Mater Res A ; 105(6): 1575-1582, 2017 06.
Article in English | MEDLINE | ID: mdl-28142219

ABSTRACT

Nucleus pulposus (NP) cells locate in the center of avascular intervertebral discs, and thus have presumably adapted to a hypoxic environment. The purpose of this study was to investigate the influences of hypoxic condition, during isolation-expansion of human NP cells, on the cellular proliferation and extracellular matrix (ECM) synthesis in later three-dimensional cultures. Human NP tissues were obtained from patients who underwent lumbar disc surgeries. Immediately after retrieval, NP tissues from each patient were divided into two aliquots for in vitro cultivation either under classical normoxic (21% O2 ) or hypoxic (3.5% O2 ) condition. After isolation-expansion processes, microtissues of NP cells were formed and the analysis was performed after one-week culture. Experiments of pretreatment with TGF-ß1 or lovastatin were designed to investigate if the isolation-expansion conditions affect the responsiveness to later exogenous treatments. Hypoxic isolation-expansion stimulated NP cell proliferation during monolayer culture. Hypoxia also upregulated mRNA levels of SOX9 and HIF-1α but downregulated type X collagen as well as improved aggrecan and type II collagen synthesis. Although TGF-ß1 had no substantial effect, lovastatin pretreatment showed a greater enhancement on type II collagen expression in hypoxic group. Normoxia negatively affected the biochemical composition of regenerated ECM attributable to downregulation of SOX9 and HIF-1α, while hypoxia enhanced cellular proliferation, improved matrix production, and maintained a functional phenotype of NP cells. Hypoxic isolation-expansion of human NP cells is important to achieve better regenerative cells for later cultivation or cell transplantation. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 1575-1582, 2017.


Subject(s)
Extracellular Matrix/metabolism , Nucleus Pulposus/cytology , Oxygen/metabolism , Adult , Cell Culture Techniques/methods , Cell Hypoxia , Cell Proliferation , Cell Separation/methods , Cell Survival , Cells, Cultured , Collagen/genetics , Collagen/metabolism , Extracellular Matrix/genetics , Gene Expression Regulation , Humans , Hydroxyproline/genetics , Hydroxyproline/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Nucleus Pulposus/metabolism , Young Adult
9.
Biochemistry ; 55(51): 7112-7122, 2016 Dec 27.
Article in English | MEDLINE | ID: mdl-27981829

ABSTRACT

Conantokins (con) are short γ-carboxyglutamate (Gla)-containing polypeptides expressed by marine snails that function as antagonists of N-methyl-d-aspartate receptor (NMDAR) ion channels. The Gla residues govern structural conformations and antagonistic activities of the conantokins. In addition to Gla, some conantokins, e.g., conRl-B, also contain a hydroxyproline (HyP or O) residue, which in this case is centrally located in the peptide at position 10. Because conRl-B specifically inhibits ion channels of GluN2B subunit-containing heterotetrameric NMDARs, we evaluated the unusual role of HyP10 in this effect. To accomplish this goal, we examined synthetic variants of conRl-B in which HyP10 was either deleted (conRl-B[ΔO10]) or replaced with alanine (conRl-B[O10A]) or proline (conRl-B[O10P]). The solution structures of these variants were determined by nuclear magnetic resonance spectroscopy. Deletion of HyP10, or replacement of HyP10 with Ala10, attenuated the distortion in the central region of the apo-conRl-B helix and allowed Mg2+-complexed end-to-end α-helix formation. The inhibitory properties of these variants were assessed by measuring NMDA/Gly-stimulated intracellular Ca2+ influx in mice neurons. ConRl-B[O10P] retained its NMDAR ion channel inhibitory activity in wild-type (WT) neurons but lost its GluN2B specificity, whereas conRl-B[ΔO10] showed overall diminished inhibitory function. ConRl-B[O10A] showed attenuated inhibitory function but retained its GluN2B specificity. Thus, HyP10 plays a critical role in maintaining the structural integrity of conRl-B, which can be correlated with its GluN2B subunit-selective inhibition. Weakened inhibition by conRl-B was also observed in neurons lacking either the GluN2C or GluN2D subunit, compared to WT neurons. This suggests that GluN2C and GluN2D are also required for inhibition by conRl-B.


Subject(s)
1-Carboxyglutamic Acid/chemistry , Hydroxyproline/chemistry , Peptides/pharmacology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , 1-Carboxyglutamic Acid/genetics , 1-Carboxyglutamic Acid/metabolism , Alanine/chemistry , Alanine/genetics , Alanine/metabolism , Amino Acid Sequence , Animals , Calcium/metabolism , Cells, Cultured , Conus Snail/chemistry , Hydroxyproline/genetics , Hydroxyproline/metabolism , Magnetic Resonance Spectroscopy , Mice, Knockout , Models, Molecular , Mutation , Neurons/drug effects , Neurons/metabolism , Neurons/physiology , Peptides/chemistry , Peptides/genetics , Proline/chemistry , Proline/genetics , Proline/metabolism , Protein Multimerization , Protein Structure, Secondary , Receptors, N-Methyl-D-Aspartate/chemistry , Receptors, N-Methyl-D-Aspartate/genetics , Solutions
10.
Sci Rep ; 6: 38720, 2016 12 08.
Article in English | MEDLINE | ID: mdl-27929065

ABSTRACT

In the aconitase superfamily, which includes the archetypical aconitase, homoaconitase, and isopropylmalate isomerase, only aconitase X is not functionally annotated. The corresponding gene (LhpI) was often located within the bacterial gene cluster involved in L-hydroxyproline metabolism. Screening of a library of (hydroxy)proline analogues revealed that this protein catalyzes the dehydration of cis-3-hydroxy-L-proline to Δ1-pyrroline-2-carboxylate. Furthermore, electron paramagnetic resonance and site-directed mutagenic analyses suggests the presence of a mononuclear Fe(III) center, which may be coordinated with one glutamate and two cysteine residues. These properties were significantly different from those of other aconitase members, which catalyze the isomerization of α- to ß-hydroxy acids, and have a [4Fe-4S] cluster-binding site composed of three cysteine residues. Bacteria with the LhpI gene could degrade cis-3-hydroxy-L-proline as the sole carbon source, and LhpI transcription was up-regulated not only by cis-3-hydroxy-L-proline, but also by several isomeric 3- and 4-hydroxyprolines.


Subject(s)
Aconitate Hydratase/chemistry , Bacteria/enzymology , Hydro-Lyases/chemistry , Iron-Sulfur Proteins/chemistry , Aconitate Hydratase/genetics , Aconitate Hydratase/metabolism , Bacteria/genetics , Catalytic Domain , Hydro-Lyases/genetics , Hydro-Lyases/metabolism , Hydroxyproline/chemistry , Hydroxyproline/genetics , Hydroxyproline/metabolism , Iron-Sulfur Proteins/genetics , Iron-Sulfur Proteins/metabolism
11.
J Inherit Metab Dis ; 39(5): 625-632, 2016 09.
Article in English | MEDLINE | ID: mdl-27139199

ABSTRACT

BACKGROUND: Hydroxyprolinemia is an inborn error of amino acid degradation that is considered a non-disease. Known for more than 50 years, its genetic cause and prevalence have remained unclear. In MS/MS newborn screening, the mass spectrum of hydroxyproline cannot be differentiated from isoleucine and leucine causing false positive newborn screening test results for maple syrup urine disease (MSUD). METHODS: We studied two siblings with hydroxyprolinemia via exome sequencing and confirmed the candidate gene in five further individuals with hydroxyprolinemia, who were all characterized biochemically and clinically. The prevalence was calculated based on the number of individuals with hydroxyprolinemia detected via MS/MS newborn screening at our centre from 2003 to 2014. RESULTS: In six cases, we identified homozygous or compound heterozygous mutations in PRODH2 as the underlying genetic cause of hydroxyprolinemia. One individual was heterozygous for a deletion in PRODH2 and had an intermittent biochemical phenotype with partial normalization of hydroxyproline concentrations. In one further individual with persistent hydroxyprolinemia no mutation in PRODH2 was found, raising the possibility of another defect of hydroxyproline degradation yet to be identified as the underlying cause of hydroxyprolinemia. Plasma hydroxyproline concentrations were clearly elevated in all individuals with biallelic mutations in PRODH2. All studied individuals remained asymptomatic, giving further evidence that hydroxyprolinemia is a benign condition. The estimated prevalence of hydroxyprolinemia in Germany is about one in 47,300 newborns. CONCLUSION: Our results establish mutations in PRODH2 as a cause of human hydroxyprolinemia via impaired dehydrogenation of hydroxyproline to delta1-pyroline-3-hydroxy-5-carboxylic acid, and we suggest PRODH2 be renamed HYPDH. Hydroxyprolinemia is an autosomal-recessively inherited benign condition. It is a frequent cause of false positive screening results for MSUD, the prevalence being about 2.5 times higher than that of MSUD.


Subject(s)
Amino Acid Metabolism, Inborn Errors/etiology , Amino Acid Metabolism, Inborn Errors/genetics , Mutation/genetics , Oxidoreductases Acting on CH-NH Group Donors/deficiency , Child , Child, Preschool , Female , Germany , Heterozygote , Homozygote , Humans , Hydroxyproline/genetics , Infant , Infant, Newborn , Male , Maple Syrup Urine Disease/etiology , Maple Syrup Urine Disease/genetics , Neonatal Screening/methods , Oxidoreductases Acting on CH-NH Group Donors/genetics , Phenotype , Prevalence , Proline Oxidase/genetics
12.
J Pharm Pharmacol ; 66(12): 1786-95, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25209833

ABSTRACT

OBJECTIVE: This study was to explore the antifibrotic effect and the possible mechanism of total polysaccharides of Yupingfeng (YPF-P) on bleomycin (BLM)-induced pulmonary fibrosis in rats. METHODS: Pulmonary fibrosis was induced in Sprague-Dawley rats by BLM (5 mg/kg), killed 14 and 28 days after BLM administration by abdominal aorta exsanguination and removed the lungs. Lung coefficient was counted at the same time. Besides, H&E and Masson's trichrome staining for histopathological changes of lung tissues were observed. Additionally, western blotting and immunohistochemical staining techniques were used to detect expression of transforming growth factor-ß1 (TGF-ß1), type I collagen (Col-I) and α-smooth muscle actin (α-SMA). Finally, the levels of Col-I and hydroxyproline (HYP) in lung tissues were also utilized. KEY FINDINGS: YPF-P alleviated the increase of lung coefficient induced by BLM instillation in pulmonary fibrosis rat, pathologic changes and collagen distribution were obviously ameliorated, while the increase of α-SMA-positive cells and TGF-ß1 expression was prevented after YPF-P treatment. Moreover, the contents of HYP and Col-I were decreased in YPF-P group. CONCLUSIONS: YPF-P had antifibrotic effect in experiment, which may reduce the synthesis and promote the deposition of Col-I via suppressing the increase of TGF-ß1-mediated activation of myofibroblasts.


Subject(s)
Bleomycin/pharmacology , Collagen Type I/metabolism , Drugs, Chinese Herbal/therapeutic use , Polysaccharides/therapeutic use , Pulmonary Fibrosis/prevention & control , Transforming Growth Factor beta1/metabolism , Actins/metabolism , Animals , Blotting, Western , Collagen Type I/genetics , Disease Models, Animal , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/chemistry , Hydroxyproline/genetics , Hydroxyproline/metabolism , Lung/drug effects , Lung/metabolism , Lung/pathology , Polysaccharides/administration & dosage , Polysaccharides/chemistry , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/metabolism , Pulmonary Fibrosis/pathology , Rats, Sprague-Dawley , Transforming Growth Factor beta1/genetics
13.
Food Chem Toxicol ; 56: 450-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23500768

ABSTRACT

Astaxanthin, a member of the carotenoid family, is the only known ketocarotenoid transported into the brain by transcytosis through the blood-brain barrier. However, whether astaxanthin has antifibrotic functions is unknown. In this study, we investigated the effects of astaxanthin on transforming growth factor ß1-mediated and bleomycin-induced pulmonary fibrosis in vitro and in vivo. The results showed that astaxanthin significantly improved the structure of the alveoli and alleviated collagen deposition in vivo. Compared with the control group, the astaxanthin-treated groups exhibited downregulated protein expressions of α-smooth muscle actin, vimentin, hydroxyproline, and B cell lymphoma/leukemia-2 as well as upregulated protein expressions of E-cadherin and p53 in vitro and in vivo. Astaxanthin also inhibited the proliferation of activated A549 and MRC-5 cells at median inhibitory concentrations of 40 and 30 µM, respectively. In conclusion, astaxanthin could relieve the symptoms and halt the progression of pulmonary fibrosis, partly by preventing transdifferentiation, inhibiting proliferation, and promoting apoptosis of activated cells.


Subject(s)
Apoptosis/drug effects , Cell Proliferation/drug effects , Cell Transdifferentiation/drug effects , Pulmonary Fibrosis/prevention & control , Actins/genetics , Actins/metabolism , Antigens, CD , Bleomycin/adverse effects , Bleomycin/metabolism , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Cadherins/genetics , Cadherins/metabolism , Cell Line, Tumor , Collagen/metabolism , Down-Regulation , Humans , Hydroxyproline/genetics , Hydroxyproline/metabolism , Lung/cytology , Lung/drug effects , Lung/metabolism , Microscopy, Electron, Transmission , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/metabolism , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Up-Regulation , Vimentin/genetics , Vimentin/metabolism , Xanthophylls/pharmacology
14.
J Biol Chem ; 287(48): 40598-610, 2012 Nov 23.
Article in English | MEDLINE | ID: mdl-23060441

ABSTRACT

BACKGROUND: α1(V) is an extensively modified collagen chain important in disease. RESULTS: Comprehensive mapping of α1(V) post-translational modifications reveals unexpectedly large numbers of X-position hydroxyprolines in Gly-X-Y amino acid triplets. CONCLUSION: The unexpected abundance of X-position hydroxyprolines suggests a mechanism for differential modification of collagen properties. SIGNIFICANCE: Positions, numbers, and occupancy of modified sites can provide insights into α1(V) biological properties. Aberrant expression of the type V collagen α1(V) chain can underlie the connective tissue disorder classic Ehlers-Danlos syndrome, and autoimmune responses against the α1(V) chain are linked to lung transplant rejection and atherosclerosis. The α1(V) collagenous COL1 domain is thought to contain greater numbers of post-translational modifications (PTMs) than do similar domains of other fibrillar collagen chains, PTMs consisting of hydroxylated prolines and lysines, the latter of which can be glycosylated. These types of PTMs can contribute to epitopes that underlie immune responses against collagens, and the high level of PTMs may contribute to the unique biological properties of the α1(V) chain. Here we use high resolution mass spectrometry to map such PTMs in bovine placental α1(V) and human recombinant pro-α1(V) procollagen chains. Findings include the locations of those PTMs that vary and those PTMs that are invariant between these α1(V) chains from widely divergent sources. Notably, an unexpectedly large number of hydroxyproline residues were mapped to the X-positions of Gly-X-Y triplets, contrary to expectations based on previous amino acid analyses of hydrolyzed α1(V) chains from various tissues. We attribute this difference to the ability of tandem mass spectrometry coupled to nanoflow chromatographic separations to detect lower-level PTM combinations with superior sensitivity and specificity. The data are consistent with the presence of a relatively large number of 3-hydroxyproline sites with less than 100% occupancy, suggesting a previously unknown mechanism for the differential modification of α1(V) chain and type V collagen properties.


Subject(s)
Collagen Type V/chemistry , Hydroxyproline/chemistry , Amino Acid Motifs , Amino Acid Sequence , Animals , Cattle , Collagen Type V/genetics , Collagen Type V/metabolism , Humans , Hydroxyproline/genetics , Hydroxyproline/metabolism , Mass Spectrometry , Molecular Sequence Data , Peptide Mapping
15.
J Biol Chem ; 287(39): 32674-88, 2012 Sep 21.
Article in English | MEDLINE | ID: mdl-22833679

ABSTRACT

L-hydroxyproline (4-hydroxyproline) mainly exists in collagen, and most bacteria cannot metabolize this hydroxyamino acid. Pseudomonas putida and Pseudomonas aeruginosa convert L-hydroxyproline to α-ketoglutarate via four hypothetical enzymatic steps different from known mammalian pathways, but the molecular background is rather unclear. Here, we identified and characterized for the first time two novel enzymes, D-hydroxyproline dehydrogenase and Δ(1)-pyrroline-4-hydroxy-2-carboxylate (Pyr4H2C) deaminase, involved in this hypothetical pathway. These genes were clustered together with genes encoding other catalytic enzymes on the bacterial genomes. D-hydroxyproline dehydrogenases from P. putida and P. aeruginosa were completely different from known bacterial proline dehydrogenases and showed similar high specificity for substrate (D-hydroxyproline) and some artificial electron acceptor(s). On the other hand, the former is a homomeric enzyme only containing FAD as a prosthetic group, whereas the latter is a novel heterododecameric structure consisting of three different subunits (α(4)ß(4)γ(4)), and two FADs, FMN, and [2Fe-2S] iron-sulfur cluster were contained in αßγ of the heterotrimeric unit. These results suggested that the L-hydroxyproline pathway clearly evolved convergently in P. putida and P. aeruginosa. Pyr4H2C deaminase is a unique member of the dihydrodipicolinate synthase/N-acetylneuraminate lyase protein family, and its activity was competitively inhibited by pyruvate, a common substrate for other dihydrodipicolinate synthase/N-acetylneuraminate lyase proteins. Furthermore, disruption of Pyr4H2C deaminase genes led to loss of growth on L-hydroxyproline (as well as D-hydroxyproline) but not L- and D-proline, indicating that this pathway is related only to L-hydroxyproline degradation, which is not linked to proline metabolism.


Subject(s)
Bacterial Proteins/metabolism , Carbon-Nitrogen Lyases/metabolism , Evolution, Molecular , Hydroxyproline/metabolism , Oxidoreductases/metabolism , Pseudomonas aeruginosa/enzymology , Pseudomonas putida/enzymology , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Carbon-Nitrogen Lyases/chemistry , Carbon-Nitrogen Lyases/genetics , Hydroxyproline/chemistry , Hydroxyproline/genetics , Oxidoreductases/chemistry , Oxidoreductases/genetics , Pseudomonas aeruginosa/genetics , Pseudomonas putida/genetics , Substrate Specificity
16.
Biochem Biophys Res Commun ; 414(3): 592-7, 2011 Oct 28.
Article in English | MEDLINE | ID: mdl-21982774

ABSTRACT

An octapeptide of the adipokinetic hormone (AKH) peptide family is identified in the corpora cardiaca of the stink bug, Nezara viridula, by ESI-MS(N) (electrospray ionization multistage MS). This is the second AKH in N. viridula and it has a hydroxyproline residue at position 6, whereas the major AKH (known as Panbo-RPCH) has Pro as the sixth amino acid residue. The correct sequence assignment of [Hyp(6)]-Panbo-RPCH is confirmed by retention time and MS spectra of the synthetic peptide. Various extraction procedures were followed to ascertain whether the hydroxylation is an artefact of extraction, or whether it is due to a true post-translational modification at the prohormone level. The proline hydroxylation is unique for invertebrate neuropeptides, while it has been described in the vertebrate gonadotropin-releasing hormone (GnRH). The current finding is another piece of evidence that AKH and GnRH form a peptide superfamily and are closely related evolutionarily. Biologically, [Hyp(6)]-Panbo-RPCH is active in vivo as an AKH, causing hyperlipaemia in the stink bug at low doses, indicating again that it is an endogenous, mature and functional hormone in this insect species.


Subject(s)
Evolution, Molecular , Gonadotropins/chemistry , Heteroptera/metabolism , Hydroxyproline/chemistry , Insect Hormones/chemistry , Neuropeptides/chemistry , Oligopeptides/chemistry , Pyrrolidonecarboxylic Acid/analogs & derivatives , Animals , Gonadotropins/genetics , Heteroptera/genetics , Hydroxyproline/genetics , Insect Hormones/genetics , Neuropeptides/genetics , Oligopeptides/genetics , Pyrrolidonecarboxylic Acid/chemistry , Spectrometry, Mass, Electrospray Ionization
17.
Am J Respir Cell Mol Biol ; 45(1): 127-35, 2011 Jul.
Article in English | MEDLINE | ID: mdl-20870892

ABSTRACT

Patients receiving thoracic radiation often develop pulmonary injury and fibrosis. Currently, there are no effective measures to prevent or treat these conditions. We tested whether blockade of the chemokine, CC chemokine ligand (CCL) 3, and its receptors, CC chemokine receptor (CCR) 1 and CCR5, can prevent radiation-induced lung inflammation and fibrosis. C57BL/6J mice received thoracic radiation, and the interaction of CCL3 with CCR1 or CCR5 was blocked using genetic techniques, or by pharmacologic intervention. Lung inflammation was assessed by histochemical staining of lung tissue and by flow cytometry. Fibrosis was measured by hydroxyproline assays and collagen staining, and lung function was studied by invasive procedures. Irradiated mice lacking CCL3 or its receptor, CCR1, did not develop the lung inflammation, fibrosis, and decline in lung function seen in irradiated wild-type mice. Pharmacologic treatment of wild-type mice with a small molecule inhibitor of CCR1 also prevented lung inflammation and fibrosis. By contrast, mice lacking CCR5 were not protected from radiation-induced injury and fibrosis. The selective interaction of CCL3 with its receptor, CCR1, is critical for radiation-induced lung inflammation and fibrosis, and these conditions can be largely prevented by a small molecule inhibitor of CCR1.


Subject(s)
Chemokine CCL3/metabolism , Gamma Rays/adverse effects , Lung/metabolism , Radiation Injuries, Experimental/metabolism , Radiation Pneumonitis/metabolism , Receptors, CCR1/metabolism , Animals , Chemokine CCL3/genetics , Hydroxyproline/genetics , Hydroxyproline/metabolism , Lung/pathology , Mice , Mice, Knockout , Phenylurea Compounds/pharmacology , Piperidines/pharmacology , Radiation Injuries, Experimental/genetics , Radiation Injuries, Experimental/pathology , Radiation Injuries, Experimental/prevention & control , Radiation Pneumonitis/genetics , Radiation Pneumonitis/pathology , Radiation Pneumonitis/prevention & control , Receptors, CCR1/antagonists & inhibitors , Receptors, CCR1/genetics , Receptors, CCR5/genetics , Receptors, CCR5/metabolism
18.
Plant J ; 63(4): 662-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20545889

ABSTRACT

Extensins, hydroxyproline-rich repetitive glycoproteins with Ser-Hyp(4) motifs, are structural proteins in plant cell walls. The leucine-rich repeat extensin 1 (LRX1) of Arabidopsis thaliana is an extracellular protein with both a leucine-rich repeat and an extensin domain, and has been demonstrated to be important for cell-wall formation in root hairs. lrx1 mutants develop defective cell walls, resulting in a strong root hair phenotype. The extensin domain is essential for protein function and is thought to confer insolubilization of LRX1 in the cell wall. Here, in vivo characterization of the LRX1 extensin domain is described. First, a series of LRX1 extensin deletion constructs was produced that led to identification of a much shorter, functional extensin domain. Tyr residues can induce intra- and inter-molecular cross-links in extensins, and substitution of Tyr in the extensin domain by Phe led to reduced activity of the corresponding LRX1 protein. An additional function of Tyr (or Phe) is provided by the aromatic nature of the side chain. This suggests that these residues might be involved in hydrophobic stacking, possibly as a mechanism of protein assembly. Finally, modified LRX1 proteins lacking Tyr in the extensin domain are still insolubilized in the cell wall, indicating strong interactions of extensins within the cell wall in addition to the well-described Tyr cross-links.


Subject(s)
Arabidopsis Proteins/metabolism , Cell Wall/metabolism , Glycoproteins/metabolism , Tyrosine/metabolism , Amino Acid Sequence , Arabidopsis/genetics , Arabidopsis/metabolism , Arabidopsis Proteins/chemistry , Arabidopsis Proteins/genetics , Binding Sites/genetics , Cell Wall/chemistry , Cell Wall/genetics , Genetic Complementation Test , Glycoproteins/chemistry , Glycoproteins/genetics , Hydroxyproline/genetics , Hydroxyproline/metabolism , Leucine-Rich Repeat Proteins , Molecular Sequence Data , Mutation , Plants, Genetically Modified , Proteins/chemistry , Proteins/genetics , Proteins/metabolism , Solubility , Tyrosine/genetics
19.
Exp Anim ; 59(2): 157-70, 2010.
Article in English | MEDLINE | ID: mdl-20484849

ABSTRACT

The aim of this study was to develop and characterize a rat glomerulonephritis model, which progresses to renal fibrosis and renal failure. A single immunization of female WKY rats with more than 10 microg of recombinant alpha3(IV)NC1 protein caused severe proteinuria followed by progressive increases in plasma creatinine and blood urea nitrogen (BUN) level within 42 days. Sequential histopathological evaluation revealed crescent formation in glomeruli followed by tubular dilation and interstitial fibrosis. Hydroxyproline content and expression of type I collagen and smooth muscle actin genes in the renal cortex increased as renal dysfunction progressed. Furthermore, the TGF-beta1 level in the renal cortex also increased. In the evaluation of antinephritic agents in this model, prednisolone and mycophenolate mofetil (MMF) treatment significantly decreased plasma creatinine and BUN, and suppressed renal fibrosis and histological changes involving crescent formation, compared with the vehicle-treated nephritic rats, whereas lisinopril treatment failed to improve renal function and histology. We demonstrated that immunization of female WKY rats with a sufficient dose of recombinant alpha3(IV)NC1 induces end-stage kidney disease accompanied by renal fibrosis. The relatively short period needed to induce the disease and the high incidence of functional and structural changes were considered a great advantage of this model for clarifying the mechanisms of progressive glomerulonephritis and for evaluating agents used to treat renal failure.


Subject(s)
Autoantigens/adverse effects , Collagen Type IV/adverse effects , Glomerulonephritis/physiopathology , Kidney Failure, Chronic/physiopathology , Recombinant Proteins/adverse effects , Actins/genetics , Actins/metabolism , Animals , Collagen Type I/genetics , Collagen Type I/metabolism , Creatinine/blood , Disease Models, Animal , Female , Gene Expression , Glomerulonephritis/chemically induced , Glomerulonephritis/drug therapy , Glomerulonephritis/metabolism , Hydroxyproline/genetics , Hydroxyproline/metabolism , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/chemically induced , Kidney Failure, Chronic/drug therapy , Kidney Failure, Chronic/metabolism , Kidney Function Tests , Lisinopril/therapeutic use , Mycophenolic Acid/analogs & derivatives , Mycophenolic Acid/therapeutic use , Prednisolone/therapeutic use , Rats , Rats, Inbred WKY , Transforming Growth Factor beta1/metabolism
20.
J Biol Chem ; 285(4): 2580-90, 2010 Jan 22.
Article in English | MEDLINE | ID: mdl-19940144

ABSTRACT

Collagen triple helices are stabilized by 4-hydroxyproline residues. No function is known for the much less common 3-hydroxyproline (3Hyp), although genetic defects inhibiting its formation cause recessive osteogenesis imperfecta. To help understand the pathogenesis, we used mass spectrometry to identify the sites and local sequence motifs of 3Hyp residues in fibril-forming collagens from normal human and bovine tissues. The results confirm a single, essentially fully occupied 3Hyp site (A1) at Pro(986) in A-clade chains alpha1(I), alpha1(II), and alpha2(V). Two partially modified sites (A2 and A3) were found at Pro(944) in alpha1(II) and alpha2(V) and Pro(707) in alpha2(I) and alpha2(V), which differed from A1 in sequence motif. Significantly, the distance between sites 2 and 3, 237 residues, is close to the collagen D-period (234 residues). A search for additional D-periodic 3Hyp sites revealed a fourth site (A4) at Pro(470) in alpha2(V), 237 residues N-terminal to site 3. In contrast, human and bovine type III collagen contained no 3Hyp at any site, despite a candidate proline residue and recognizable A1 sequence motif. A conserved histidine in mammalian alpha1(III) at A1 may have prevented 3-hydroxylation because this site in chicken type III was fully hydroxylated, and tyrosine replaced histidine. All three B-clade type V/XI collagen chains revealed the same three sites of 3Hyp but at different loci and sequence contexts from those in A-clade collagen chains. Two of these B-clade sites were spaced apart by 231 residues. From these and other observations we propose a fundamental role for 3Hyp residues in the ordered self-assembly of collagen supramolecular structures.


Subject(s)
Collagen/chemistry , Collagen/metabolism , Hydroxyproline/chemistry , Hydroxyproline/metabolism , Adult , Amino Acid Sequence , Animals , Bone and Bones/chemistry , Bone and Bones/metabolism , Cartilage/chemistry , Cartilage/metabolism , Cattle , Chickens , Collagen/genetics , Collagen Type I/chemistry , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen Type II/chemistry , Collagen Type II/genetics , Collagen Type II/metabolism , Collagen Type III/chemistry , Collagen Type III/genetics , Collagen Type III/metabolism , Collagen Type V/chemistry , Collagen Type V/genetics , Collagen Type V/metabolism , Collagen Type XI/chemistry , Collagen Type XI/genetics , Collagen Type XI/metabolism , Extracellular Matrix Proteins/chemistry , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Humans , Hydroxyproline/genetics , Molecular Sequence Data , Protein Processing, Post-Translational , Tandem Mass Spectrometry , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...